In acutely ill inpatients, benefits and harms of anticoagulants for VTE prophylaxis were assessed

Sudeep Shivakumar

doi:10.7326/J22-0089

In acutely ill inpatients, benefits and harms of anticoagulants for VTE prophylaxis were assessed

Ann Intern Med. 2022 Nov;175(11):JC128. doi: 10.7326/J22-0089. Epub 2022 Nov 1.

Author

Sudeep Shivakumar¹

Affiliation

¹ Dalhousie University, Halifax, Nova Scotia, Canada (S.S.).

PMID: 36315952
DOI: 10.7326/J22-0089

Abstract

Eck RJ, Elling T, Sutton AJ, et al. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis. BMJ. 2022;378:e070022. 35788047.

Publication types

Comment

MeSH terms

Anticoagulants* / adverse effects
Hospitalization
Hospitals
Humans
Inpatients
Risk Factors
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / prevention & control

Substances

Anticoagulants